Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from untreated and Aza treated AML3 cells

ABSTRACT: AML3 cells were treated with Azacytidine and compared against untreated cells

ORGANISM(S): Homo sapiens

PROVIDER: GSE55123 | GEO | 2014/07/01

SECONDARY ACCESSION(S): PRJNA242395

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression data from untreated and Aza treated AML3 cells

Project description:AML3 cells were treated with Azacytidine and compared against untreated cells We used RNA-Seq to detail the global programme of gene expression in human untreated and Azacytidine treated AML3 cells

2014-07-01 | E-GEOD-55123 | biostudies-arrayexpress

Genome-wide methylation maps for untreated and Aza treated AML3 cells

Project description:AML3 cells were treated with Azacytidine and compared against untreated cells

2014-07-01 | GSE55124 | GEO

Genome-wide methylation maps for untreated and Aza treated AML3 cells

Project description:AML3 cells were treated with Azacytidine and compared against untreated cells Examination of methylation status in human untreated and Azacytidine treated AML3 cells

2014-07-01 | E-GEOD-55124 | biostudies-arrayexpress

Aza treated AML3 cells

Project description:Aza treated AML3 cells

| PRJNA242393 | ENA

Escherichia coli: untreated versus 5-azacytidine-treated expression profiles

Project description:DNA microarray experiments were used to compare gene expression profiles of untreated and 5-azacytidine treated Escherichia coli at both logarithmic phase and early stationary phase The goal was to determine the effect of cytosine DNA methylation loss on gene expression (5-azacytidine is a methylation inhibitor)

2016-09-24 | GSE73707 | GEO

Aza treated AML3 cells

Project description:This SuperSeries is composed of the SubSeries listed below.

2014-07-01 | GSE55125 | GEO

RNA-seq Analysis of OCI-AML3 Cells Treated with Different Compounds

Project description:Acute myeloid leukemia (AML) remains a challenging hematologic malignancy, necessitating the exploration of novel treatment strategies. In this study, we investigated the effects of all-trans retinoic acid (ATRA), AM80, and their combination treatments with GSK-LSD1 and MB3 on gene expression in OCI-AML3 cells.

2025-02-01 | GSE256476 | GEO

Aza treated AML3 cells

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-07-01 | E-GEOD-55125 | biostudies-arrayexpress

Epigenetic Silencing of LTR12C family in OCI-AML3

Project description:Chromatin accessibility at LTR12C family has been shown to b required to maintain stemness properties in leukemic stem cells. Here using CRISPRi epigenetic silencing strategy, we targetted LTR12C family in OCI-AML3 cell line. Our ATAC-seq and CUT&RUN data demonstrate efficient targeting and silencing of entire family using only 4 sgRNAs. Epigenetic silencing of this family leads to slower growth in targeted OCI-AML3 cells compared to control cells.

2026-01-16 | GSE288771 | GEO